Through increasing the phosphorylation of AKT (AKT serine/threonine kinase 1) and GSK-3β, AM404 at low dose ameliorated cognitive deficit and reduced Aβ, Tau hyperphosphorylation, and inflammation in hyperglycemic 3×Tg-AD mice [69]. Here, MAPT is linked to Alzheimer disease.